Vanguard Global Advisers »

Enanta Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $291k 23k 12.63

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Enanta Pharmaceuticals

Henderson Group
BlackRock
Farallon Capital Management
Krensavage Asset Management
Vanguard Group
Deep Track Capital
Vanguard Capital Management
Vanguard Portfolio Management
Millennium Management
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
Hillsdale Investment Management
Marshall Wace

View all funds holding Enanta Pharmaceuticals